As of 2026-09-13, the Relative Valuation of Medicenna Therapeutics Corp (MDNA.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.42 CAD, the upside of Medicenna Therapeutics Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-09-11 | -1.53 |
| 2026-09-10 | -1.55 |
| 2026-09-09 | -1.58 |
| 2026-09-08 | -1.69 |
| 2026-09-04 | -1.73 |
| 2026-09-03 | -1.73 |
| 2026-09-02 | -1.69 |
| 2026-09-01 | -1.73 |
| 2026-08-31 | -1.73 |
| 2026-08-28 | -1.75 |
| 2026-08-27 | -1.69 |
| 2026-08-26 | -1.73 |
| 2026-08-25 | -1.73 |
| 2026-08-24 | -1.60 |
| 2026-08-21 | -1.51 |
| 2026-08-20 | -1.53 |
| 2026-08-19 | -1.53 |
| 2026-08-18 | -1.60 |
| 2026-08-17 | -1.62 |
| 2026-08-14 | -1.69 |
| 2026-08-13 | -1.47 |
| 2026-08-12 | -1.49 |
| 2026-08-11 | -1.47 |
| 2026-08-10 | -1.46 |
| 2026-08-07 | -1.38 |
| 2026-08-06 | -1.44 |
| 2026-08-05 | -1.40 |
| 2026-08-04 | -1.33 |
| 2026-07-31 | -1.33 |
| 2026-07-30 | -1.29 |
| 2026-07-29 | -1.29 |
| 2026-07-28 | -1.31 |
| 2026-07-27 | -1.27 |
| 2026-07-24 | -1.29 |
| 2026-07-23 | -1.27 |
| 2026-07-22 | -1.29 |
| 2026-07-21 | -1.29 |
| 2026-07-20 | -1.29 |
| 2026-07-17 | -1.29 |
| 2026-07-16 | -1.29 |
| 2026-07-15 | -1.34 |
| 2026-07-14 | -1.34 |
| 2026-07-13 | -1.36 |
| 2026-07-10 | -1.36 |
| 2026-07-09 | -1.38 |
| 2026-07-08 | -1.44 |
| 2026-07-07 | -1.46 |
| 2026-07-06 | -1.42 |
| 2026-07-03 | -1.46 |
| 2026-07-02 | -1.40 |